Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 14
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
Authors Hisanaga K, Uchino H , Kakisu N, Miyagi M , Yoshikawa F, Sato G, Isobe K, Kishi K, Homma S, Hirose T
Received 7 May 2021
Accepted for publication 7 May 2021
Published 6 July 2021 Volume 2021:14 Pages 3109—3110
Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773—781.
Page 775, left column, third paragraph, line 4, the text “(p<0.5)” should read “(p<0.05)”.
Page 775, left column, second line from the bottom, the text “11.3±20.8” should read “113.0±20.8”.
Page 776, Table 1, Plasma glucose (mg/dl) row, Unmatched, Non-DM (n=64) column, the value “11.3±20.8” should read “113.0±20.8”.
The authors apologize for these errors.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.